Updates ·
Health notices · Monday 5 October
3 notices from the agencies today, in plain words, each with the original linked.
Ebola outbreak linked to Bundibugyo virus continues in DRC
World Health Organization (WHO) · Outbreak
The WHO says Ebola disease caused by Bundibugyo virus remains active in the Democratic Republic of the Congo (DRC), with sustained transmission increasing reported cases and deaths.
As of 15 July 2026, 2124 confirmed cases and 828 deaths have been reported in the DRC. On 13 July 2026, German authorities reported a laboratory-confirmed case in a humanitarian worker evacuated from the DRC.
In Uganda, no new cases have been reported since 21 June 2026. After the most recent case was discharged on 16 July, Uganda started a 42-day period of enhanced surveillance before the outbreak can be declared over.
CDC reports updated confirmed U.S. measles cases and outbreaks
Centers for Disease Control and Prevention (CDC) · Guidance
If you live in the U.S. and are not protected from measles, you could be at higher risk if there’s an outbreak in your area. Measles spreads through the air when an infected person coughs or sneezes.
CDC reports that 95% of confirmed 2026 cases are linked to outbreaks, and it defines a measles outbreak as 3 or more related cases. CDC also notes some communities have lower MMR (measles, mumps, rubella) vaccination coverage.
CDC posts weekly totals based on confirmed cases reported to CDC as of noon on Thursdays. State and local health departments may have more up-to-date information on ongoing outbreaks.
FDA approval for Gadavist (gadobutrol) MRI contrast
FDA · Approval
If you need an MRI, the Food and Drug Administration (FDA) has approved GADAVIST (gadobutrol), a gadolinium-based contrast agent. Contrast helps doctors see areas more clearly on MRI images.
It is indicated for MRI in people (including pediatric patients and term neonates) when imaging is meant to detect central nervous system areas with disrupted blood brain barrier and/or abnormal vascularity.
It’s also indicated for MRI of malignant breast disease, magnetic resonance angiography of supra-aortic or renal artery disease, and cardiac MRI to assess myocardial perfusion and late gadolinium enhancement in coronary artery disease.